← Leaderboards
Erika A Waters
Washington University
$6,585,228
Attributed
$9,263,146
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,228,504 · 6
AHRQ$34,642 · 1
By mechanism
R01$9,042,169 · 5
R03$186,335 · 1
R13$34,642 · 1
Top collaborators
- James A Shepperd4 shared
- Laura D. Scherer3 shared
- Matthew James Ehrhardt1 shared
Most similar at Washington University
Same institution · by research overlap
- Timothy J Eberlein$71,591,509
- Timothy M Lohman$21,274,874
- L David Sibley$48,261,605
- Jonathan David Gitlin$8,492,819
- Matthew J. Silva$20,876,359
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectBehaviorSurveysFutureSamplingTranslatingCommunicationCommunitiesPreventDesignPersonsParticipantHealth BehaviorMemberClinical ApplicationRaceFosteringHigh RiskPhysical ActivityBaseEducationMalignant NeoplasmsScienceSocial
Grant awards (19)
Evaluation of Cardiovascular Health Outcomes among Survivors 2 (ECHOS-2)$772,418
R01 · FY2025 · CA
Understanding and addressing rejection of personalized cancer risk information$631,686
R01 · FY2025 · CA
Investigating ELSI issues that may facilitate or impede clinical translation of epigenomic research$559,917
R01 · FY2025 · ES · contact PI
Understanding and addressing rejection of personalized cancer risk information$706,184
R01 · FY2024 · CA
Investigating ELSI issues that may facilitate or impede clinical translation of epigenomic research$571,771
R01 · FY2024 · ES · contact PI
Understanding and addressing rejection of personalized cancer risk information$660,513
R01 · FY2023 · CA
Investigating ELSI issues that may facilitate or impede clinical translation of epigenomic research$560,266
R01 · FY2023 · ES · contact PI
Investigating ELSI issues that may facilitate or impede clinical translation of epigenomic research$626,490
R01 · FY2022 · ES · contact PI
Child Asthma Exacerbation: Role of Caregiver Risk Beliefs$575,496
R01 · FY2021 · HL · contact PI
Child Asthma Exacerbation: Role of Caregiver Risk Beliefs$729,624
R01 · FY2020 · HL · contact PI
Child Asthma Exacerbation: Role of Caregiver Risk Beliefs$660,427
R01 · FY2019 · HL · contact PI
Child Asthma Exacerbation: Role of Caregiver Risk Beliefs$619,488
R01 · FY2018 · HL · contact PI
COMMUNICATING MULTIPLE DISEASE RISKS: A TRANSLATION OF RISK PREDICTION SCIENCE$266,267
R01 · FY2018 · CA · contact PI
COMMUNICATING MULTIPLE DISEASE RISKS: A TRANSLATION OF RISK PREDICTION SCIENCE$389,066
R01 · FY2017 · CA · contact PI
A CONFERENCE GRANT TO IMPLEMENT COMPARATIVE EFFECTIVENESS RESEARCH INTO POLICY$34,642
R13 · FY2017 · HS · contact PI
COMMUNICATING MULTIPLE DISEASE RISKS: A TRANSLATION OF RISK PREDICTION SCIENCE$338,614
R01 · FY2016 · CA · contact PI
COMMUNICATING MULTIPLE DISEASE RISKS: A TRANSLATION OF RISK PREDICTION SCIENCE$373,942
R01 · FY2015 · CA · contact PI
DONT KNOW RESPONSES TO PERCEIVED RISK ITEMS: IMPLICATION FOR HEALTH BEHAVIOR$83,928
R03 · FY2015 · CA · contact PI
DONT KNOW RESPONSES TO PERCEIVED RISK ITEMS: IMPLICATION FOR HEALTH BEHAVIOR$102,407
R03 · FY2014 · CA · contact PI